These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15476879)

  • 21. HIV-1 subtype C in vitro growth and coreceptor utilization.
    Ndung'u T; Sepako E; McLane MF; Chand F; Bedi K; Gaseitsiwe S; Doualla-Bell F; Peter T; Thior I; Moyo SM; Gilbert PB; Novitsky VA; Essex M
    Virology; 2006 Apr; 347(2):247-60. PubMed ID: 16406460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
    Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines.
    Atchison RE; Gosling J; Monteclaro FS; Franci C; Digilio L; Charo IF; Goldsmith MA
    Science; 1996 Dec; 274(5294):1924-6. PubMed ID: 8943208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
    Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
    Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM; Santos-Costa Q
    Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains.
    Samson M; Edinger AL; Stordeur P; Rucker J; Verhasselt V; Sharron M; Govaerts C; Mollereau C; Vassart G; Doms RW; Parmentier M
    Eur J Immunol; 1998 May; 28(5):1689-700. PubMed ID: 9603476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.
    Brelot A; Heveker N; Pleskoff O; Sol N; Alizon M
    J Virol; 1997 Jun; 71(6):4744-51. PubMed ID: 9151868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line.
    Soda Y; Shimizu N; Jinno A; Liu HY; Kanbe K; Kitamura T; Hoshino H
    Biochem Biophys Res Commun; 1999 May; 258(2):313-21. PubMed ID: 10329384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
    Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
    J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates.
    Ross TM; Bieniasz PD; Cullen BR
    J Virol; 1998 Mar; 72(3):1918-24. PubMed ID: 9499044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV.
    Shimizu N; Tanaka A; Oue A; Mori T; Ohtsuki T; Apichartpiyakul C; Uchiumi H; Nojima Y; Hoshino H
    AIDS; 2009 Apr; 23(7):761-9. PubMed ID: 19307942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.
    Nakayama D; Misumi S; Mukai R; Tachibana K; Umeda M; Shibata H; Takamune N; Shoji S
    J Biochem; 2005 Nov; 138(5):571-82. PubMed ID: 16272569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.
    Gray L; Sterjovski J; Churchill M; Ellery P; Nasr N; Lewin SR; Crowe SM; Wesselingh SL; Cunningham AL; Gorry PR
    Virology; 2005 Jul; 337(2):384-98. PubMed ID: 15916792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay.
    Vödrös D; Tscherning-Casper C; Navea L; Schols D; De Clercq E; Fenyö EM
    Virology; 2001 Dec; 291(1):1-11. PubMed ID: 11878871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity.
    Zhou N; Zhang X; Fan X; Argyris E; Fang J; Acheampong E; DuBois GC; Pomerantz RJ
    Virology; 2003 Dec; 317(1):84-94. PubMed ID: 14675627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.